Latest news
DXB: Advancing kidney disease therapies with global deals and a diversified, risk-managed approach - TradingViewTradingView · Thu, 06 Aug 2026 22:21:44 GMTDXB:ASX Announcement - Dimerix Presents at Bioshares Summit 2026 - 06 Aug 2026 - Market IndexMarket Index · Thu, 06 Aug 2026 04:10:01 GMTDimerix Limited (SBMJF) Presents at 2026 Bioshares Biotech Summit - New Zealand - Slideshow - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 03:04:21 GMTDimerix CEO Presents Company Diversification Strategy and DMX-652 Asset at Bioshares Summit 2026 - KalkineKalkine · Thu, 06 Aug 2026 02:54:16 GMTASX Quarterly Health Wrap: Licensing deals, clinical and commercial milestones - stockhead.com.austockhead.com.au · Fri, 31 Jul 2026 02:31:33 GMTDimerix (ASX:DXB) Builds Pipeline Momentum With Phase 3 Progress and New Commercial Partnership - KalkineKalkine · Thu, 30 Jul 2026 01:53:00 GMTDimerix Drives Clinical Progress with New Funding and Patent - KalkineKalkine · Wed, 29 Jul 2026 02:53:18 GMTDimerix (ASX:DXB) Expands Kidney Pipeline With DMX-652 Acquisition and Long-Dated Patent Protection - KalkineKalkine · Tue, 28 Jul 2026 13:13:00 GMT